MARCKS shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

MARCKS shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
MARCKS shRNA Plasmid (h)

Product Specs
ItemMARCKS shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-35857-SH
Quantity20 µg
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namemyristoylated alanine rich protein kinase C substrate
NCBI Gene Aliases80K-L, MACS, PKCSL, PRKCSL
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer CellsCancersFebruary 10, 2021Kim YE, Kim EK, Song MJ, Kim TY, Jang HH, Kang D.

(2) Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutationsScientific reportsAugust 1, 2017Rao G, Pierobon M, Kim IK, Hsu WH, Deng J, Moon YW, Petricoin EF, Zhang YW, Wang Y, Giaccone G.

(3) MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasisOncotargetJune 21, 2016Yang Z, Xu S, Jin P, Yang X, Li X, Wan D, Zhang T, Long S, Wei X, Chen G, et al.

(4) Myristoylated alanine-rich C kinase substrate (MARCKS) regulates the expression of proinflammatory cytokines in macrophages through activation of p38/JNK MAPK and NF-κBCellular immunologyAugust 1, 2015Lee SM, Suk K, Lee WH.

(5) Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survivalOncogeneFebruary 26, 2015Bickeböller M, Tagscherer KE, Kloor M, Jansen L, Chang-Claude J, Brenner H, Hoffmeister M, Toth C, Schirmacher P, Roth W, et al.

(6) NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinasesLeukemiaFebruary 1, 2011Reddy MM, Fernandes MS, Salgia R, Levine RL, Griffin JD, Sattler M.

Be the First to Write a Review!